Amplify Weight Loss Drug & Treatment ETF (THNR)

NYSEARCA: THNR · Real-Time Price · USD
23.12
-0.16 (-0.67%)
Sep 10, 2025, 4:00 PM - Market closed
-0.67%
Assets$4.23M
Expense Ratio0.59%
PE Ratio17.71
Shares Out180,000
Dividend (ttm)$0.22
Dividend Yield0.95%
Ex-Dividend DateDec 30, 2024
Payout Frequencyn/a
Payout Ratio16.84%
Volume6,787
Open23.11
Previous Close23.28
Day's Range23.09 - 23.21
52-Week Low18.56
52-Week High27.75
Betan/a
Holdings24
Inception DateMay 21, 2024

About THNR

Fund Home Page

The Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments.

Asset Class Equity
Category Health
Region Global
Stock Exchange NYSEARCA
Ticker Symbol THNR
ETF Provider Amplify Investments
Index Tracked VettaFi Weight Loss Drug & Treatment Index

Top 10 Holdings

66.97% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY11.68%
Novo Nordisk A/SNVO8.59%
Regeneron Pharmaceuticals, Inc.REGN7.30%
Amgen Inc.AMGN6.44%
Chugai Pharmaceutical Co., Ltd.45195.90%
AbbVie Inc.ABBV5.59%
AstraZeneca PLCAZN5.58%
CSPC Pharmaceutical Group Limited10935.32%
Gilead Sciences, Inc.GILD5.30%
Merck & Co., Inc.MRK5.27%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Dec 30, 2024$0.2199Dec 31, 2024
Full Dividend History

Performance

THNR had a total return of -13.68% in the past year, including dividends. Since the fund's inception, the average annual return has been -6.33%.

News

SILJ, HACK, THNR: Trends in Thematic Investing

Amplify Junior Silver Miners ETF (SILJ) is up 28% year-to-date. Christian Magoon discusses the outlook for cybersecurity stocks, as Amplify's Cybersecurity ETF (HACK) is up 8% year-to-date.

Other symbols: HACKSILJ
1 year ago - Schwab Network

Why Investors Haven't Feasted on Two New Weight-Loss ETFs

Two new weight-loss exchange-traded funds (ETFs) launched in May have yet to whet investors' appetite, possibly due to their expensive fees and concentrated bets.

Other symbols: OZEM
1 year ago - Investopedia